Topic
The Future of Clinical Oncology Next Generation Sequencing: Decentralized vs. Centralized
Description
Explore the latest findings from the NGS DxBook regarding decentralization trends and gain insights from industry leaders as we discuss the impact of decentralization and centralization on the future of clinical oncology.
What to Expect:
• Presentation: Key findings on market structures in NGS.
• Panel Discussion: Insights from top experts in the industry
• Q&A Session: Your chance to ask questions and engage with the panel.
Moderator
Rishi Kayathi, DeciBio
Stephane Budel, DeciBio
Panelists
George Daneker Jr. MD
Chief Clinical Officer, GM of Oncology at Myriad
Vik Vaz
Head of Strategy, Market Intelligence at Illumina
David Westenberg
Managing Director, Equity Research at Piper Sandler
Amber Leigh
Amber Leigh Consulting
Jerome Madison
Vice President of Product Management at Labcorp
Shawn Levy
Chief Science Officer at Element Biosciences
Don’t miss out on this opportunity to stay ahead in the evolving world of clinical oncology NGS!
Learn more about DeciBio's DxBooks here: https://www.decibio.com/product/dxbooks
Duration
01:06:00
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.